|
|
|
Volumn 57, Issue 1, 1999, Pages 153-156
|
|
Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
DRUG DERIVATIVE;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
OMEPRAZOLE;
PROTON PUMP;
RANITIDINE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG SCREENING;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MICROBIOLOGY;
REVIEW;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
CLINICAL TRIALS;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
FAMOTIDINE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
OMEPRAZOLE;
PROTON PUMPS;
RANITIDINE;
|
|
EID: 0032610569
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (9)
|
